Is IQVIA Holdings Stock a Buy?
IQVIA Holdings (NYSE: IQV), a contract research organization (CRO) formed through the $9 billion 2016 merger of Quintiles and IMS Health, provides outsourced services and technology to healthcare companies. This lesser-known healthcare services giant employs approximately 67,000 people across 100 countries.
Image Source: Getty Images.
IQVIA's R&D solutions unit helps companies -- including everything from the largest multinational pharmaceutical company to virtual biotechs -- set up and manage clinical trials. With a global footprint, IQVIA helps identify clinical trial sites, finds appropriate patients, coordinates with local labs, and handles day-to-day clinical trial operations to cut down time frames and improve the quality of data. It claims more than 250 clinical development customers, including 13 of the top 20 pharma companies.
Source Fool.com
